Log on / register
BioMed Central home | Journals A-Z | Feedback | Support

Pre-publication history

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

Shalini L Kulasingam email, Steve Benard email, Ruanne V Barnabas email, Nathalie Largeron email and Evan R Myers email

Cost Effectiveness and Resource Allocation 2008, 6:4doi:10.1186/1478-7547-6-4

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript10 Jul 2007
Reviewer's ReportRaymond Hutubessy27 Sep 2007
Reviewer's ReportRuth Brown06 Oct 2007
Resubmission - Version 2ManuscriptAuthors' comments03 Jan 2008
Resubmission - Version 3ManuscriptAuthors' comments05 Feb 2008
Resubmission - Version 4Manuscript11 Feb 2008
Accepted15 Feb 2008
© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions